Bioequivalence Study of Azilsartan Medoxomil 80 mg Tablets (Gedeon Richter Plc., Hungary) and Edarbi® 80 mg Tablets (JSC Nizhpharm, Russia)
Clinical trial NCT06990204 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06990204
- Sponsor
- Gedeon Richter Plc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-06
- Primary completion
- 2025-07-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.